Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,352 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early neuroborreliosis with leg paresis mimicking herpes zoster.
Tegtmeyer J, Abeck F, Matthews H, Christolouka M, Kött J, Schmiedel S, Schneider SW, Koch T. Tegtmeyer J, et al. Among authors: koch t. J Eur Acad Dermatol Venereol. 2024 Apr;38(4):e329-e330. doi: 10.1111/jdv.19601. Epub 2023 Nov 20. J Eur Acad Dermatol Venereol. 2024. PMID: 37907272 No abstract available.
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial.
Koch T, Dahlke C, Fathi A, Kupke A, Krähling V, Okba NMA, Halwe S, Rohde C, Eickmann M, Volz A, Hesterkamp T, Jambrecina A, Borregaard S, Ly ML, Zinser ME, Bartels E, Poetsch JSH, Neumann R, Fux R, Schmiedel S, Lohse AW, Haagmans BL, Sutter G, Becker S, Addo MM. Koch T, et al. Lancet Infect Dis. 2020 Jul;20(7):827-838. doi: 10.1016/S1473-3099(20)30248-6. Epub 2020 Apr 21. Lancet Infect Dis. 2020. PMID: 32325037 Free PMC article. Clinical Trial.
Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, Dahlke C, Kobbe R, Santer R, Koch T, Fathi A, Seco BMS, Ly ML, Schmiedel S, Schwinge D, Serna S, Sellrie K, Reichardt NC, Seeberger PH, Addo MM, Loeffler FF, On Behalf Of The Id-Uke Covid-Study Group. Heidepriem J, et al. Among authors: koch t. Pathogens. 2021 Apr 6;10(4):438. doi: 10.3390/pathogens10040438. Pathogens. 2021. PMID: 33917609 Free PMC article.
Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome.
Fathi A, Dahlke C, Krähling V, Kupke A, Okba NMA, Raadsen MP, Heidepriem J, Müller MA, Paris G, Lassen S, Klüver M, Volz A, Koch T, Ly ML, Friedrich M, Fux R, Tscherne A, Kalodimou G, Schmiedel S, Corman VM, Hesterkamp T, Drosten C, Loeffler FF, Haagmans BL, Sutter G, Becker S, Addo MM. Fathi A, et al. Among authors: koch t. Nat Commun. 2022 Jul 19;13(1):4182. doi: 10.1038/s41467-022-31557-0. Nat Commun. 2022. PMID: 35853863 Free PMC article.
Prospective Single-Center Cohort Study on HIV Pre-exposure Prophylaxis Reveals Transient but Relevant Elevations in Transaminase Levels in Some Participants Albeit Otherwise High Tolerability.
Weimann L, Schäfer G, Matthews H, Florey M, Scheiter R, Hüfner A, Jordan S, Grenz M, Schmiedel S, Schulze Zur Wiesch J, Degen O, Koch T. Weimann L, et al. Among authors: koch t. J Acquir Immune Defic Syndr. 2023 May 1;93(1):e1-e3. doi: 10.1097/QAI.0000000000003170. J Acquir Immune Defic Syndr. 2023. PMID: 36881817 No abstract available.
The COVID-19 Vaccine Landscape.
Koch T, Fathi A, Addo MM. Koch T, et al. Adv Exp Med Biol. 2021;1318:549-573. doi: 10.1007/978-3-030-63761-3_31. Adv Exp Med Biol. 2021. PMID: 33973199 Review.
1,352 results